ZTS vs MRK

	ZTS Zoetis Inc.	MRK Merck & Co., Inc.
Price	$81.03	$145.27
Sector	Health Care	Health Care
X-Ray Score	69	33
Valuation	90	22
Growth	48	33
Profitability	72	44
Financial health	60	21
Dividends	69	56
Fair value	$112	$116
Verdict	Undervalued +39%	Overvalued -20%
Revenue (TTM)	$9.5B	$66.6B
Operating margin	36.9%	11.6%
Return on capital	26.7%	6.1%
Revenue growth (3y)	5.4%	3.1%
Free-cash-flow yield	6.8%	4.5%
Net debt / EBITDA	1.8×	6.1×
Dividend yield	2.6%	2.3%

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.